Physician profile
Radhika Mehra
NPI 1134351182
$1,507.64
in general payments reported to CMS, 2019-2025
8 companies · $222 in 2025
The $222 reported for 2025 was more than what 78% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $136 · 2022: $48.68 · 2023: $537 · 2024: $199 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $958.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $468.40 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $462.38 | 2019-2023 | Camzyos, Eliquis |
| Abbvie INC. | $231.60 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.24 | 2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $94.88 | 2019-2023 | Xarelto |
| Allergan, INC. | $50.98 | 2019 | |
| Novartis Pharmaceuticals Corporation | $46.53 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $19.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Radhika Mehra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.